Jordan Leef is a seasoned healthcare entrepreneur and venture capitalist with over a decade of life science venture creation experience. Mr. Leef currently serves as the CFO, CBO and Co-Founder of Pyramid Biosciences, an early stage biotechnology company with a drug discovery platform based on modulation of the TRK receptors. Most recently, Mr. Leef served as CBO and interim-CFO of Metamark Genetics, a urologic oncology company. Mr. Leef also served as a Principal Venture Capitalist and member of the Healthcare Investment Team at Safeguard Scientifics (NYSE: SFE), a publicly-traded venture capital firm, where he invested broadly in diagnostic, medical device, healthIT and therapeutic companies. Prior to Safeguard, Mr. Leef served as a Senior Associate with MentorTech Ventures, a Philadelphia-based venture capital firm that invests in seed and early-stage companies. During his time at MentorTech, Mr. Leef also served as a Senior Associate for SVM Israel, a hybrid fund-of-funds investing in Israeli private equity and venture capital funds as well as selectively co-investing alongside those funds. Prior to joining MentorTech, Mr. Leef was a Financial Analyst at Pharos Capital Group, a private equity firm located in Nashville and Dallas. In this capacity, Mr. Leef worked as a member of the Pharos investment team to provide growth and later-stage capital for businesses in the healthcare, business services and technology industries. Prior to becoming an investor, Mr. Leef worked in the Biotechnology Equity Research Group at C.E. Unterberg, Towbin (now Collin Stewart) in New York City. Mr. Leef also previously worked at Pfizer, Inc. (NYSE: PFE) in the U.S. Clinical Operations and Business Development Divisions of the Specialty Products Cluster. Mr. Leef graduated from the Wharton School at the University of Pennsylvania.